BELLUS Health Inc. is a listed company. Its directors and officers file their transactions with SEDI. Nothing new has been filed by managers of BELLUS Health Inc. in twelve months, the latest record being from 22 June 2023.
Our records for BELLUS Health Inc. go back to 2016, with 21 purchases and 27 sales on the open market in total.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 140 declarations
BELLUS Health Inc. is a biopharmaceutical company focused on developing treatments for chronic diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.